NovaBay Pharma (NBY) Reports Q1 Loss of $0.28/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Basic and diluted (in Dollars per share): -0.34
Today's EPS Names:
INM, TRI, CRVL, More
Financial Fact:
Basic and diluted (in Dollars per share): -0.34
Today's EPS Names:
INM, TRI, CRVL, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q1 EPS of ($0.28), versus ($0.13) reported last year. Revenue for the quarter came in at $1.5 million, versus $2.9 million reported last year.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Expeditors Int'l (EXPD) Tops Q3 EPS by 45c
- Arch Capital (ACGL) PT Raised to $106 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
